HPV vaccinations: a Middle Eastern and north African dilemma

被引：21

作者：

Baghi, Hossein Bannazadeh ^{[1
,2
,3
]}

Yousefi, Bahman ^{[2
]}

Oskouee, Mahin Ahangar ^{[1
,3
]}

Aghazadeh, Mohammad ^{[2
,3
]}

机构：

[1] Tabriz Univ Med Sci, Infect & Trop Dis Res Ctr, Tabriz, Iran

[2] Tabriz Univ Med Sci, Immunol Res Ctr, Tabriz, Iran

[3] Tabriz Univ Med Sci, Fac Med, Dept Microbiol, Tabriz, Iran

来源：

LANCET INFECTIOUS DISEASES | 2017年 / 17卷 / 01期

关键词：

D O I：

10.1016/S1473-3099(16)30553-9

中图分类号：

R51 [传染病];

学科分类号：

100401 ;

摘要：

引用

页码：18 / 19

页数：2

共 6 条

[1] High-risk HPVs and human carcinomas in the Syrian population [J].

Al Moustafa, Ala-Eddin ;

Ghabreau, Lina ;

Akil, Nizar ;

Rastam, Samer ;

Alachkar, Amal ;

Yasmeen, Amber .

FRONTIERS IN ONCOLOGY, 2014, 4

[2]

[Anonymous], 2016, PAPILLOMAVIRUS RELAT

[3] Prophylactic HPV vaccination: past, present, and future [J].

Castle, P. E. ;

Maza, M. .

EPIDEMIOLOGY AND INFECTION, 2016, 144 (03) :449-468

[4]

Delong Mewed R, 2005, REPROD HEALTH MATTER, V25, P49

[5]

ICO Information Centre on HPV and Cancer (HPV Information Centre, HUMAN

[6] Implementation of Human Papillomavirus Immunization in the Developing World [J].

Kane, Mark A. ;

Serrano, Beatriz ;

de Sanjose, Silvia ;

Wittet, Scott .

VACCINE, 2012, 30 :F192-F200

← 1 →